Biochemical characterization and novel isolation of pure estrogen receptor hormone-binding domain

Journal of Steroid Biochemistry and Molecular Biology

Volumn 58, Issue 5-6, 1996, Pages 467-477

  Coffer, Arnold ^a   Cavailles, Vincent ^a,b   Knowles, Phillip ^a   Pappin, Darryl ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI;

ESTROGEN; ESTROGEN RECEPTOR;

ANIMAL; ARTICLE; BINDING SITE; ESCHERICHIA COLI; GENE TRANSFER; GENETICS; METABOLISM; MOUSE; RADIOASSAY;

ANIMALS; BINDING SITES; ESCHERICHIA COLI; ESTROGENS; GENE TRANSFER TECHNIQUES; MICE; RADIOLIGAND ASSAY; RECEPTORS, ESTROGEN;

EID: 0030202556     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(96)00068-4     Document Type: Article

References (33)

1. Kumar V., Green S., Staub A. and Chambon P.: Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J. 5 (1986) 2231-2236.
2. McDonnel D. P., Nawaz Z., Densmore C., Weigel N. L., Pham T. A., Clark J. H. and O'Malley B. W.: High level expression of biologically active estrogen receptor in Saccaromyces cerevisiae. J. Steroid Biochem. Molec. Biol. 39 (1991) 291-297.
3. Wooge C. H., Nilsson G. M., Heierson A., McDonnel D. P. and Katzenellenbogen B. S.: Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast and mammalian cells. Molec. Endocr. 6 (1992) 861-869.
4. Salomonsson M., Haggblad J., O'Malley B. W. and Sitbon G. M.: The human estrogen receptor hormone binding domain dimerizes independently of ligand activation. J. Steroid Biochem. Molec. Biol. 48 (1994) 447-452.
5. Seielstad D. A., Carlson K. E., Katznellenbogen J. A., Kushner P. J. and Greene G. L.: Molecular characterisation by mass spectrometry of the human estrogen receptor ligand-binding domain expressed in Escherichia coli. Molec. Endocr. 9 (1995) 647-658.
6. Bourguet W., Ruff M., Chambon P., Gronemeyer H. and Moras D.: Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α. Nature 375 (1995) 377-382.
7. Bourguet W., Ruff M., Bonnier D., Granger F., Boeglin M., Chambon P., Moras D. and Gronemeyer H.: Purification, functional characterization of the ligand binding domain of the retinoid X receptor. Protein Expr. Purif. 6 (1995) 604-608.
8. Ferre-D'Amare A. and Burley S. K.: Use of dynamic light scattering to assess crystallizability of macromolecules and macromolecular assemblies. Structure 2 (1994) 357-359.
9. Coffer A. I., Lewis K. M., Brockas A. J. and King R. J. B.: Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res. 45 (1985) 3686-3693.
10. Cavailles V., Dauvois S., Daniellan P. S. and Parker M. G.: Interaction of proteins with transcriptionally active estrogen receptors. Proc. natn. Acad. Sci. U.S.A. 91 (1994) 10009-10013.
11. Scatchard G.: The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 51 (1949) 660-672.
12. Coffer A. I., Fellows J., Young S., Pappin D. and Rahman D.: Purification and characterisation of biologically active scatter factor from ras-transformed NIH 3T3 conditioned medium. Biochem. J. 278 (1991) 35-41.
13. Coffer A., Sinnett-Smith J. and Rozengurt E.: Bombesin receptor from Swiss 3T3 cells: Affinity chromatography and reconstitution into phospholipid vesicles. FEBS Lett. 275 (1990) 159-164.
14. Meng C. K., Mann M. and Fenn J. B.: Of protons or proteins. Z. Phys. D. 10 (1988) 361-368.
15. Bradford M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72 (1976) 248-254.
16. Gonenne A. and Ernst R.: Solubilisation of membrane proteins by sulfobetaines, novel zwitterionic surfactants. Analyt. Biochem. 87 (1978) 28-38.
17. Chalkley G. E., Knowles P. P., Whitehead P. C. and Coffer A. I.: Biochemical characterisation of purified human wild-type p53 overexpressed in insect cells. Eur. J. Biochem. 221 (1994) 167-175.
18. Coffer A. I. and King R. J. B.: Antibodies to estradiol receptor from human myometrium. J. Steroid Biochem. 14 (1981) 1229-1235.
19. Wakeling A. E., Dukes M. and Bowler J.: A potent specific pure antiestrogen with clinical potential. Cancer Res. 51 (1991) 3867-3873.
20. Jordan V. C.: Studies on the estrogen receptor in breast cancer - 20 years as a target for the treatment and prevention of cancer. Breast Cancer Res. Treat. 36 (1995) 267-285.
21. Katzenellenbogen B. S., Norman M. J., Eckert R. L., Peltz S. W. and Mangel W.: Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res. 44 (1984) 112-119.
22. Robertson D. W., Katzenellenbogen J. A., Long D. J., Rorke E. A. and Katzenellenbogen B.: Tamoxifen antioestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. J. Steroid Biochem. 16 (1982) 1-13.
23. McPherson A., Koszelak S., Axelrod H., Day J., Williams R., Robinson L., McGrath M. and Cascio D.: An experiment regarding crystallisation of soluble proteins in the presence of β-octyl glucoside. J. Biol. Chem. 261 (1986) 1969-1975.
24. Garavito R. M. and Rosenbusch J. P.: Three-dimensional crystals of an integral membrane protein: an initial X-ray analysis. J. Cell. Biol. 86 (1980) 327-329.
25. Dalman F. C., Scherrer L. C., Taylor L. P., Akil H. and Pratt W. B.: Localization of the 90-kDa heat shock protein-binding site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J. Biol. Chem. 66 (1991) 3482-3490.
26. Smith D. F., Stensgard B. A., Welch W. J. and Toft D. O.: Assembly of progesterone receptor with heat shock proteins and receptor activation are ATP mediated events. J. Biol. Chem. 267 (1992) 1350-1356.
27. Inano K., Curtis S. W., Korach K. S., Omata S. and Horigome T.: Heat shock protein 90 strongly stimulates the binding of purified estrogen receptor to its responsive element. J. Biochem. 116 (1994) 759-766.
28. Hutchinson K. A., Stancato L. F., Owens-Grillo J. K., Johnson J., Krishna P., Toft D. O. and Pratt W. B.: The 23-kDa acidic protein in reticulocyte lysate is the weakly bound component of the hsp foldosome that is required for assembly of the glucocorticoid receptor into a functional heterocomplex with hsp90. J. Biol. Chem. 270 (1995) 18841-18847.
29. Chambraud B., Berry M., Redeuilh G., Chambon P. and Baulieu E.-E.: Several regions of human estrogen receptor are involved in the formation of receptor-heat shock protein 90 complexes. J. Biol. Chem. 265 (1990) 20686-20691.
30. Medici N., Minucci S., Nigro V., Abbondanza C., Armetta I., Molinari A. M. and Puca G. A.: Metal binding sites of the estradiol receptor from calf uterus and their possible role in the regulation of receptor function. Biochemistry 28 (1989) 212-219.
31. Hay, R. W.: In Bio-inorganic Chemistry. Halsted, New York (1984).
32. Sulkowski E.: The saga of IMAC and MIT. Bioessays 5 (1989) 170-175.
33. Coffer A. I. and Knowles P. P.: Divalent metal ions induce conformational change in pure, human wild-type p53 tumor suppressor protein. Biochim. Biophys. Acta 1209 (1994) 279-285.